Unstablecoronaryarterydisease,suchasunstableanginaandnon-q-wavemyocardialinfarction:Subcutaneousinjection120IU/kgweight,twicedaily.Themaximumdoseis10000IU/12h.Treatmentshouldlastatleast6daysandmaybeex
Ifnecessary,theactivityofheparinsodiumcanbemonitoredbymeasuringanti-xa.TreatmentofacutedeepvenousthrombosisDextroheparinsodiumcanbeinjectedsubcutaneouslyonceadayortwiceaday.Usage:200IU/kgbodyweight,su
Treatmentofacutedeepvenousthrombosis.Preventcoagulationinextracorporealcirculationduringhemodialysisandbloodfiltrationinpatientswithacuteorchronicrenalfailure.Treatmentofunstablecoronaryarterydisease,
Chemicalname:dheparinsodium,thisproductbelongstolowmolecularweightheparinsodium.Composition:1single-dosepre-fillingsyringeDaheparinsodium2500IU(anti-xa)5000IU(anti-xa)7500IU(anti-xa)Sodiumchloridemode